Eosinophilic Esophagitis Market
According to Intent Market Research, the Eosinophilic Esophagitis Market is expected to grow from USD 0.8 billion in 2023 at a CAGR of 12.4% to touch USD 1.9 billion by 2030. The Eosinophilic Esophagitis Market is dominated by key players such as AstraZeneca, Sanofi, Pfizer, Takeda Pharmaceuticals, GlaxoSmithKline (GSK), Allergan, AbbVie, Regeneron Pharmaceuticals, Bayer AG, Novartis, Eli Lilly and Co., Amgen, Biogen Inc., Teva Pharmaceutical Industries, Celgene Corporation